Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aussyspitzon Feb 28, 2020 2:19pm
55 Views
Post# 30748305

RE:RE:RE:RE:RE:RE:At 2.48pm today - a big head fake.

RE:RE:RE:RE:RE:RE:At 2.48pm today - a big head fake.In my opinion the first rule regarding a speculative investment paly is to never invest more than you can afford to lose should the stock go to zero. If I already owned shares I would hold them and wait as this is probably the worst time to sell particularly with COVID19 weighing the market down.

Tax losses are usually better taken at the end of the year where you can use them to offset any capital gains. Additionally, no real harm in holding in the event that Liminal actually secures a partnership and the BLA is resubmitted as their forward looking statements indicate.

However,  with that said despite what appears to be a bargain price this is far from what I would consider a bargain or slam dunk particularly given their very sketchy credibility and past performance include Thomvests practices/involvement/management.

This stock is currently ranked 357th of 375 stocks for stocks followed by anaylsts within this sector. It has 3 analysts and all recommending holding. I personally wouldn't establish or add to a position.

I think most investors should easily be able to find a better quality stock either within or even outside this sector that may be taking an unfair short term beating due to the recent downturn with better odds of success and likely better rate of return particularly once the COVID19 scare passes and one way or another it will eventually pass.
<< Previous
Bullboard Posts
Next >>